The most important proangiogenic agent is VEGF acting as a potent mediator of angiogenesis by autocrine and paracrine activity affecting proliferation and survival of leukaemia/lymphoma cells in addition to tumour vascularisation. The gene discussed is VEGFA; the disease is leukemia.